Page last updated: 2024-08-16

propafenone and daunorubicin

propafenone has been researched along with daunorubicin in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (66.67)18.2507
2000's2 (22.22)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Burghofer, S; Chiba, P; Ecker, G; Moser, A; Richter, E; Tell, B1
Ayesh, S; Lan, LB; Lyubimov, E; Pashinsky, I; Stein, WD1
Chiba, P; Cordes, HP; Csöllei, J; Ecker, G; Hitzler, M; Schaper, KJ; Schmid, D; Seydel, JK; Visser, K1
Chiba, P; Ecker, G; Schaper, KJ1
Chiba, P; Ecker, G; Hitzler, M; Jäger, W; Richter, E; Tell, B1
Chiba, P; Ecker, G; Hitzler, M; Rebitzer, S; Richter, E1

Reviews

1 review(s) available for propafenone and daunorubicin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for propafenone and daunorubicin

ArticleYear
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
    Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7

    Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties

2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Synthesis, pharmacologic activity, and structure-activity relationships of a series of propafenone-related modulators of multidrug resistance.
    Journal of medicinal chemistry, 1995, Jul-07, Volume: 38, Issue:14

    Topics: Daunorubicin; Drug Resistance, Multiple; Drug Synergism; Etoposide; Humans; Magnetic Resonance Spectroscopy; Propafenone; Structure-Activity Relationship; Tumor Cells, Cultured

1995
Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Survival; Cyclosporine; Cytotoxins; Daunorubicin; Drug Resistance, Multiple; Humans; Propafenone; Trifluoperazine; Vinblastine

1996
Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance.
    Journal of medicinal chemistry, 1996, Nov-22, Volume: 39, Issue:24

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzofurans; Calorimetry, Differential Scanning; Cells, Cultured; Daunorubicin; Drug Resistance, Multiple; Ethanolamines; Liposomes; Magnetic Resonance Spectroscopy; Membranes, Artificial; Propafenone; Regression Analysis; Rhodamine 123; Rhodamines; Structure-Activity Relationship

1996
Estimation of the chemosensitizing activity of modulators of multi-drug resistance via combined simultaneous analysis of sigmoidal dose-response curves.
    The Journal of pharmacy and pharmacology, 1997, Volume: 49, Issue:3

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Propafenone; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

1997
Studies on propafenone-type modulators of multidrug-resistance IV1): synthesis and pharmacological activity of 5-hydroxy and 5-benzyloxy derivatives.
    Archiv der Pharmazie, 1997, Volume: 330, Issue:11

    Topics: Anti-Arrhythmia Agents; Antibiotics, Antineoplastic; Cell Line; Daunorubicin; Drug Interactions; Drug Resistance, Multiple; Humans; Propafenone; Structure-Activity Relationship

1997
Synthesis and pharmacological activity of the stereoisomers of GP-88, a propafenone-type modulator of multidrug resistance.
    Bioorganic & medicinal chemistry letters, 1998, Apr-07, Volume: 8, Issue:7

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Resistance, Multiple; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Phenyl Ethers; Propafenone; Propanols; Stereoisomerism; Tumor Cells, Cultured

1998